Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NaturalNano, Inc. Announces Filing of the Form 10K for the Year Ended December 31, 2008

Abstract:
NaturalNano, Inc. (OTC Bulletin Board: NNAN) (FWB: N3N), a developer of extended release technologies and supplier of polymer additives based on naturally occurring nanomaterials, today announced the filing of the Form 10K for the year ended December 31, 2008.

NaturalNano, Inc. Announces Filing of the Form 10K for the Year Ended December 31, 2008

Rochester, NY | Posted on April 16th, 2009

In 2008, The Nano team worked on various development projects with Fortune 500 companies. Fiabila's commercial order, announced April 14, 2009, is a result of our team's development efforts in 2008 and is a validation of our core technology of extended release in consumer products. These technologies are unique to NaturalNano and covered extensively by our patent portfolio. One of our strategic focuses for 2009 is the conversion of our joint development partnership arrangements into commercial orders. We will also be looking for opportunities to license our extensive patent portfolio in product application areas. Our current patent portfolio is displayed on our website (www.naturalnano.com). During 2009, we will be working to strengthen our management and research teams as we continue to seek commercialization opportunities for our unique proprietary technology.

"The recession does not seem to be hindering the high level of company contacts we are continuing to receive," said James Wemett, CEO of NaturalNano. "Companies are paying more attention to our specialized technology of halloysite tubes which are natural occurring, non-toxic, and environmentally friendly and importantly, are not carbon based. There is a growing awareness and interest, across numerous industry applications, of our extensive patent coverage in the extended time release area."

####

About NaturalNano, Inc.
Headquartered in Rochester, NY, NaturalNano, Inc. (OTCBB: NNAN) (FWB: N3N) develops and commercializes products and solutions for extended release attributes for consumer goods as well as polymer additives based on naturally occurring nanomaterials from halloysite. The Company offers its proprietary Pleximer(TM) line of additives for industrial polymers, plastics and composites. NaturalNano holds and licenses more than 25 patents and its applications, as well as proprietary know-how for extraction, classification, and modification of non-toxic and environmentally friendly halloysite natural tubules (HNT).

Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNanos filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.

For more information, please click here

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Tiny sensor lays groundwork for precision X-rays detection via endoscopy:Nanoscale fiber-integrated X-ray sensor opens new doors for medical imaging and radiotherapy March 29th, 2017

Researchers uncover secret of nanomaterial that makes harvesting sunlight easier March 29th, 2017

Information storage with a nanoscale twist: Discovery of a novel rotational force inside magnetic vortices makes it easier to design ultrahigh capacity disk drives March 28th, 2017

A big leap toward tinier lines: Self-assembly technique could lead to long-awaited, simple method for making smaller microchip patterns March 27th, 2017

Materials/Metamaterials

Researchers uncover secret of nanomaterial that makes harvesting sunlight easier March 29th, 2017

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Announcements

Tiny sensor lays groundwork for precision X-rays detection via endoscopy:Nanoscale fiber-integrated X-ray sensor opens new doors for medical imaging and radiotherapy March 29th, 2017

Researchers uncover secret of nanomaterial that makes harvesting sunlight easier March 29th, 2017

Information storage with a nanoscale twist: Discovery of a novel rotational force inside magnetic vortices makes it easier to design ultrahigh capacity disk drives March 28th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Patents/IP/Tech Transfer/Licensing

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Intertronics introduce new nanoparticle deagglomeration technology March 15th, 2017

Keystone Nano Announces The US FDA Has Awarded Orphan Drug Designation For Ceramides For The Treatment Of Liver Cancer November 8th, 2016

Financial Reports

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 7, 2017 January 19th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project